Experimental Meningococcal Sepsis in Mice
Author Information
Author(s): Marek Szatanik, Eva Hong, Corinne Ruckly, Morgan Ledroit, Dario Giorgini, Katarzyna Jopek, Marie-Anne Nicola, Ala-Eddine Deghmane, Muhamed-Kheir Taha
Primary Institution: Institut Pasteur, Paris, France
Hypothesis
Can an experimental model of meningococcal sepsis in transgenic mice improve understanding of its pathophysiology?
Conclusion
The study developed a transgenic mouse model that shows enhanced susceptibility to meningococcal sepsis, particularly after prior influenza infection.
Supporting Evidence
- The transgenic mice showed significantly higher bacterial counts in blood and organs compared to wild-type mice.
- Infected transgenic mice had a mortality rate of 17% after bacterial challenge.
- Cytokine levels were significantly higher in infected transgenic mice than in wild-type mice.
Takeaway
Researchers created special mice that get very sick from a type of bacteria called meningococcus, especially if they had the flu first, to help understand how to treat it better.
Methodology
The study involved creating transgenic mice, infecting them with meningococcus, and analyzing their immune response and gene expression.
Potential Biases
Potential bias in the selection of transgenic mice and the specific strains of bacteria used.
Limitations
The study was conducted in a controlled laboratory setting, which may not fully replicate human disease conditions.
Participant Demographics
Transgenic BALB/c mice expressing human transferrin.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website